國立高雄大學圖資館 |

Language: English

Back

Venture capital and the European biotechnology industry

Record Type:	Electronic resources : Monograph/item
Title/Author:	Venture capital and the European biotechnology industryWilliam Bains.
Author:	Bains, William,
Published:	Basingstoke [England] ;Palgrave Macmillan,2009.
Description:	1 online resource (viii, 220 p.) :ill.
Notes:	Description based on print version record.
Subject:	Venture capital.
Online resource:	access to fulltext (Palgrave)
ISBN:	9780230227262 (electronic bk.)

Venture capital and the European biotechnology industry
Bains, William,1955-

Venture capital and the European biotechnology industry[electronicresource] /William Bains. - Basingstoke [England] ;Palgrave Macmillan,2009. - 1 online resource (viii, 220 p.) :ill.

Description based on print version record.

Includes bibliographical references (p. 201-215) and indexes.

Introduction : the facts -- The biotechnology industry and venture capital -- Europe falls behind -- Why does Europe do so poorly? Some inadequate explanations -- Under-investment in European biotechnology -- Public markets and under-investment -- VC management of companies -- VC effects on business efficacy -- Investor blockade of business -- Pomp and circumstances -- The real VC business model -- What to do about it: government -- What to do about it: business -- References -- Index.

Why do so many European biotechnology companies fail? This book finds an answer in the behavior of the investors who dominate the industry and control the behavior of the companies they invest in. Starting froma detailed analysis of the history of the industry from its earliest days, this book cuts through the hype and mythology to identify what really happened to the biotechnology industryin Europe, what went wrong with the business, the management and the investment, and who are the controlling figures that made it happen. Bains uses real case studies anda wealth of statistical data to show how systematic under-investment and extraordinary business decisions have made European companies stunted mimics of their US counterparts. Building on an inside knowledge of how venture capital really works, he shows how this is not an accidentalside-product of European inexperience or lack of business acumen, but a necessary result of how venture capitalists run their businesses in Europe. This is an essential book for entrepreneurs, investors and policy-makers alike, as well as being avaluable information source for anyone interested in how high-tech businesses are created.

ISBN: 9780230227262 (electronic bk.)Subjects--Topical Terms:

200106
Venture capital.
Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: HD9999.B443 / E85125 2009eb

Dewey Class. No.: 660.6068/1

Venture capital and the European biotechnology industry
LDR:02918cmm 2200301Ia 4500 001 259529
003 OCoLC
005 20100709081826.0
006 m d
007 cr cnu---unuuu
008 100903s2009 enka sb 001 0 eng d
020 $a 9780230227262 (electronic bk.)
020 $a 0230227260 (electronic bk.)
035 $a (OCoLC)319175573
035 $a ocn319175573
040 $a UKPGM $b eng $c UKPGM $d YDXCP $d N $d EBLCP $d CUS
043 $a e------
049 $a APTA
050 4 $a HD9999.B443 $b E85125 2009eb
082 0 4 $a 660.6068/1 $2 22
100 1 $a Bains, William, $d 1955- $3 239895
245 1 0 $a Venture capital and the European biotechnology industry $h [electronicresource] / $c William Bains.
260 $a Basingstoke [England] ; $a New York : $b Palgrave Macmillan, $c 2009.
300 $a 1 online resource (viii, 220 p.) : $b ill.
500 $a Description based on print version record.
504 $a Includes bibliographical references (p. 201-215) and indexes.
505 0 $a Introduction : the facts -- The biotechnology industry and venture capital -- Europe falls behind -- Why does Europe do so poorly? Some inadequate explanations -- Under-investment in European biotechnology -- Public markets and under-investment -- VC management of companies -- VC effects on business efficacy -- Investor blockade of business -- Pomp and circumstances -- The real VC business model -- What to do about it: government -- What to do about it: business -- References -- Index.
520 $a Why do so many European biotechnology companies fail? This book finds an answer in the behavior of the investors who dominate the industry and control the behavior of the companies they invest in. Starting froma detailed analysis of the history of the industry from its earliest days, this book cuts through the hype and mythology to identify what really happened to the biotechnology industryin Europe, what went wrong with the business, the management and the investment, and who are the controlling figures that made it happen. Bains uses real case studies anda wealth of statistical data to show how systematic under-investment and extraordinary business decisions have made European companies stunted mimics of their US counterparts. Building on an inside knowledge of how venture capital really works, he shows how this is not an accidentalside-product of European inexperience or lack of business acumen, but a necessary result of how venture capitalists run their businesses in Europe. This is an essential book for entrepreneurs, investors and policy-makers alike, as well as being avaluable information source for anyone interested in how high-tech businesses are created.
650 0 $a Venture capital. $3 200106
650 0 $a Biotechnology industries $z Europe $x Finance. $3 460217
655 7 $a Electronic books. $2 local. $3 214472
776 0 8 $i Print version: $a Bains, William, 1955- $t Venture capital and the European biotechnology industry. $d Basingstoke [England] ; New York : Palgrave Macmillan, 2009 $z 9780230217195 $w (DLC) 2008029943 $w (OCoLC)234176084
856 4 0 $3 Palgrave Connect $u https://link.springer.com/book/10.1057/9780230227262 $z access to fulltext (Palgrave)